| Registry | NCT06188975 |
|---|---|
| Status | Available |
| Study type | Expanded access |
| Sponsor | Calico Life Sciences LLC (Industry) |
| Conditions | Advanced Solid Tumor Cancer |
| Interventions | DRUG: ABBV-CLS-484 (Drug) |
| Dates | first posted 2024-01-03, last updated 2024-01-03 |
Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Advanced Solid Tumor Cancer All trials of DRUG: ABBV-CLS-484
This is an expanded access program (EAP) for eligible participants. This program is designed to provide access to ABBV-CLS-484 prior to approval by the local regulatory agency. Availability will depend on territory eligibility. A medical doctor must decide whether the potential benefit outweighs the risk of receiving an investigational therapy based on the individual patient's medical history and program eligibility criteria.
Inclusion Criteria: \- Exclusion Criteria: \-